jpmorgan-enters-korean-otc-derivatives-market

JPMorgan enters Korean OTC derivatives market

OTC licence approval gives JPMorgan an opportunity to grow its onshore client base.
JPMorgan is set to start trading over-the-counter OTC derivatives in South Korea after winning approval from local regulators earlier this week.

The initial focus will be on the equity market, but the licence, which is issued by the Financial Supervisory Commission, approves JPMorgan to market and trade the full range of OTC derivatives. The motivation was initially driven by the equity business but the platform is also designed for other asset classes, such as credit and rates, FX and commodities, says William Lee, Asia ex-Japan head of equity derivatives.

The onshore OTC market is still relatively young in Korea but is expected to grow significantly as the regulator approves more licences and the...
¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222